Insulin aspart biosimilar (Xentria)

N/A

Report date: 2026/01/21 10:11:20

Base Information

Drug NameInsulin aspart biosimilar (Xentria)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsEndocrine System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXentria Inc
China Registration ClassN/A

Develop Information

Active CompaniesMeitheal Pharmaceuticals IncXentria Inc
Inactive CompaniesN/A
Active IndicationsEndocrine System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A